Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autologous Hematopoietic Stem Cell Transplantation

NCT04320420 is registered in ClinicalTrials.gov with Weprom as lead sponsor.

NCT NCT04320420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04320420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of an Adapted Physical Activity Program for Patients Treated With an Autologous Hematopoietic Stem Cell Transplantation
Lead sponsor
Weprom
Phase
Not applicable
Overall status
Unknown status
Start date
November 20, 2020
Completion date
October 31, 2024
Enrollment
57 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autologous transplant, lymphoma, myeloma